MedPath
FDA Approval

OLOPATADINE HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 19, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Olopatadine(1.11 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

NuCare Pharmaceuticals,Inc.

NuCare Pharmaceuticals,Inc.

010632300

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

OLOPATADINE HYDROCHLORIDE

Product Details

NDC Product Code
68071-5085
Application Number
ANDA206306
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
February 19, 2021
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACTQuantity: 0.1 mg in 1 mL
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: 22ADO53M6FClass: IACTQuantity: 5 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 6.5 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 2XG66W44KFClass: ACTIMQuantity: 1.11 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath